Buckingham Capital Management (Ohio)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $574K | Buy |
3,228
+2
| +0.1% | +$368 | 0.07% | 92 |
|
|
2024
Q3 | $637K | Buy |
3,226
+2
| +0.1% | +$373 | 0.07% | 91 |
|
|
2024
Q2 | $553K | Buy |
3,224
+2,003
| +164% | +$332K | 0.07% | 94 |
|
|
2024
Q1 | $222K | Sell |
1,221
-94
| -7% | -$16.2K | 0.03% | 121 |
|
|
2023
Q4 | $204K | Buy |
+1,315
| New | +$192K | 0.03% | 115 |
|
|
2023
Q2 | – | Sell |
-1,456
| Closed | -$232K | – | 114 |
|
|
2023
Q1 | $232K | Buy |
1,456
+4
| +0.3% | +$612 | 0.04% | 104 |
|
|
2022
Q4 | $235K | Buy |
+1,452
| New | +$223K | 0.04% | 105 |
|
|
2022
Q2 | – | Sell |
-1,369
| Closed | -$222K | – | 113 |
|
|
2022
Q1 | $222K | Sell |
1,369
-454
| -25% | -$65.9K | 0.04% | 111 |
|
|
2021
Q4 | $247K | Buy |
+1,823
| New | +$215K | 0.04% | 110 |
|
|
2021
Q3 | – | Sell |
-1,799
| Closed | -$203K | – | 123 |
|
|
2021
Q2 | $203K | Buy |
+1,799
| New | +$203K | 0.03% | 121 |
|
|
2021
Q1 | – | Sell |
-1,996
| Closed | -$214K | – | 120 |
|
|
2020
Q4 | $214K | Buy |
+1,996
| New | +$192K | 0.04% | 113 |
|
|
2020
Q1 | – | Sell |
-2,273
| Closed | -$201K | – | 122 |
|
|
2019
Q4 | $201K | Buy |
+2,273
| New | +$189K | 0.03% | 128 |
|
|
2019
Q3 | – | Sell |
-14,518
| Closed | -$1.06M | – | 131 |
|
|
2019
Q2 | $1.06M | Sell |
14,518
-26,112
| -64% | -$2.05M | 0.2% | 91 |
|
|
2019
Q1 | $3.27M | Sell |
40,630
-6,733
| -14% | -$551K | 0.64% | 47 |
|
|
2018
Q4 | $4.37M | Sell |
47,363
-2,528
| -5% | -$222K | 0.96% | 31 |
|
|
2018
Q3 | $4.72M | Sell |
49,891
-148
| -0.3% | -$14K | 0.92% | 28 |
|
|
2018
Q2 | $4.64M | Buy |
50,039
+10,032
| +25% | +$980K | 0.94% | 27 |
|
|
2018
Q1 | $3.79M | Sell |
40,007
-749
| -2% | -$82.3K | 0.79% | 35 |
|
|
2017
Q4 | $3.94M | Sell |
40,756
-2,952
| -7% | -$278K | 0.83% | 30 |
|
|
2017
Q3 | $3.88M | Sell |
43,708
-5,117
| -10% | -$390K | 0.86% | 28 |
|
|
2017
Q2 | $3.54M | Sell |
48,825
-6,603
| -12% | -$444K | 0.82% | 29 |
|
|
2017
Q1 | $3.61M | Sell |
55,428
-5,239
| -9% | -$329K | 0.85% | 29 |
|
|
2016
Q4 | $3.8M | Sell |
60,667
-6,030
| -9% | -$368K | 0.94% | 25 |
|
|
2016
Q3 | $4.21M | Sell |
66,697
-490
| -0.7% | -$31.7K | 1.08% | 20 |
|
|
2016
Q2 | $4.16M | Buy |
67,187
+463
| +0.7% | +$28.2K | 1.1% | 20 |
|
|
2016
Q1 | $3.81M | Buy |
66,724
+4,729
| +8% | +$264K | 1.04% | 23 |
|
|
2015
Q4 | $3.67M | Buy |
61,995
+1,995
| +3% | +$115K | 1.03% | 21 |
|
|
2015
Q3 | $3.27M | Buy |
60,000
+1,354
| +2% | +$88.1K | 0.96% | 21 |
|
|
2015
Q2 | $3.99M | Buy |
58,646
+2,490
| +4% | +$163K | 1.12% | 18 |
|
|
2015
Q1 | $3.29M | Buy |
56,156
+313
| +0.6% | +$18.9K | 0.95% | 22 |
|
|
2014
Q4 | $3.65M | Buy |
55,843
+8,892
| +19% | +$561K | 1.09% | 20 |
|
|
2014
Q3 | $2.71M | Buy |
46,951
+770
| +2% | +$42.7K | 0.84% | 31 |
|
|
2014
Q2 | $2.61M | Buy |
46,181
+1,755
| +4% | +$92.1K | 0.82% | 35 |
|
|
2014
Q1 | $2.28M | Buy |
44,426
+1,640
| +4% | +$82.9K | 0.77% | 38 |
|
|
2013
Q4 | $2.26M | Buy |
42,786
+2,132
| +5% | +$105K | 0.79% | 33 |
|
|
2013
Q3 | $1.8M | Buy |
40,654
+1,410
| +4% | +$62.5K | 0.73% | 38 |
|
|
2013
Q2 | $1.62M | Buy |
+39,244
| New | +$1.72M | 0.66% | 42 |
|
Other funds holding ABBV
Buckingham Capital Management (Ohio)'s ABBV Position: Q4 2024 in Review
Buckingham Capital Management (Ohio) increased its AbbVie (ABBV) stake by 0.06% in Q4 2024, buying an estimated $368 and bringing the position to 3,228 shares worth $574K. The position accounts for 0.07% of the portfolio, ranked #92.
Buckingham Capital Management (Ohio) first reported a position in ABBV in Q2 2013 and has held it in 37 quarters since. The position peaked at $4.72M in Q3 2018. 3,745 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.
- Buckingham Capital Management (Ohio) held 3,228 shares of AbbVie worth $574K as of Q4 2024.
- Buckingham Capital Management (Ohio) bought 2 AbbVie shares in Q4 2024, an estimated $368.
- AbbVie made up 0.07% of Buckingham Capital Management (Ohio)'s portfolio in Q4 2024, its #92 holding.
- Buckingham Capital Management (Ohio) first reported a position in AbbVie in Q2 2013 and has held it in 37 quarters since.
- Buckingham Capital Management (Ohio)'s AbbVie position peaked at $4.72M in Q3 2018.
- 3,745 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.
Based on Buckingham Capital Management (Ohio)'s 13F filing for Q4 2024, filed 31 Jan 2025.